Are Basic Materials Stocks Lagging Perimeter Solutions, SA (PRM) This Year? — Negative

PRM   Zacks Investment Research — November 28, 2025

Here is how Perimeter Solutions, SA (PRM) and Fortuna Mining (FSM) have performed compared to their sector so far this year.

image for news Are Basic Materials Stocks Lagging Perimeter Solutions, SA (PRM) This Year?

Are Finance Stocks Lagging Credicorp (BAP) This Year? — Negative

BAP   Zacks Investment Research — November 28, 2025

Here is how Credicorp (BAP) and The Bank of New York Mellon Corporation (BK) have performed compared to their sector so far this year.

image for news Are Finance Stocks Lagging Credicorp (BAP) This Year?

Are Investors Undervaluing CNA Financial (CNA) Right Now? — Positive

CNA   Zacks Investment Research — November 28, 2025

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

image for news Are Investors Undervaluing CNA Financial (CNA) Right Now?

Here is how Expeditors International (EXPD) and LATAM (LTM) have performed compared to their sector so far this year.

image for news Is Expeditors International of Washington (EXPD) Stock Outpacing Its Transportation Peers This Year?

LOS ANGELES, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Skye Bioscience, Inc. (“Skye” or “the Company”) (NASDAQ: SKYE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 4, 2024 and October 3, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 16, 2026.

image for news SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Why Nutanix's 18% Decline Shouldn't Surprise Investors — Negative

NTNX   Benzinga — November 28, 2025

Nutanix (NASDAQ: NTNX) fell more than 18% after reporting earnings below analyst expectations and issuing a weak forward outlook. But while the market reacted sharply to the results, the structure of this decline was already in motion.

image for news Why Nutanix's 18% Decline Shouldn't Surprise Investors

The AI chip maker has had a November to forget. Why December could be better.

image for news Nvidia Stock Falls to End Rough Month. Why History Says December Will Be a Relief.

Google drops EU antitrust complaint against Microsoft over cloud computing practices — Positive

GOOG  GOOGL  MSFT   Proactive Investors — November 28, 2025

Alphabet Inc (NASDAQ:GOOG)'s Google has withdrawn its antitrust complaint against Microsoft Corp (NASDAQ:MSFT) over the company's cloud computing practices in the European Union, following the launch of a broader EU investigation into the sector. The complaint, originally filed by Google in 2024, alleged that Microsoft engaged in anti-competitive licensing practices that locked customers into its Azure cloud platform.

image for news Google drops EU antitrust complaint against Microsoft over cloud computing practices

The heavy selling pressure might have exhausted for Grand Canyon Education (LOPE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

image for news After Plunging 24.4% in 4 Weeks, Here's Why the Trend Might Reverse for Grand Canyon Education (LOPE)

Michael Burry has warned AI giants are overstating how long their Nvidia chips will stay relevant. Bridgewater's Greg Jensen said the chips may be used to invent better chips that make them obsolete.

image for news Bridgewater's Greg Jensen echoes Michael Burry on Nvidia's AI chips — and says they could help make themselves obsolete

Can Primoris Sustain Renewables Momentum Amid Shifting Award Timing? — Positive

PRIM   Zacks Investment Research — November 28, 2025

PRIM navigates shifting timelines as rapid renewables execution boosts revenues but tightens backlog, testing momentum.

image for news Can Primoris Sustain Renewables Momentum Amid Shifting Award Timing?

Workday Q3 Earnings Beat on Strength in Subscription Services — Positive

WDAY   Zacks Investment Research — November 28, 2025

WDAY posts strong Q3 results as subscription revenues jump and AI-fueled demand drives broad customer growth.

image for news Workday Q3 Earnings Beat on Strength in Subscription Services

Is e.l.f. Beauty (ELF) a Buy as Wall Street Analysts Look Optimistic? — Neutral

ELF   Zacks Investment Research — November 28, 2025

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

image for news Is e.l.f. Beauty (ELF) a Buy as Wall Street Analysts Look Optimistic?

Earnings Growth & Price Strength Make Goldman Sachs (GS) a Stock to Watch — Positive

GS   Zacks Investment Research — November 28, 2025

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

image for news Earnings Growth & Price Strength Make Goldman Sachs (GS) a Stock to Watch

Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? — Positive

BSX   Zacks Investment Research — November 28, 2025

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?

Earnings Growth & Price Strength Make JPMorgan Chase & Co. (JPM) a Stock to Watch — Positive

JPM   Zacks Investment Research — November 28, 2025

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

image for news Earnings Growth & Price Strength Make JPMorgan Chase & Co. (JPM) a Stock to Watch

Wall Street Analysts See Core & Main (CNM) as a Buy: Should You Invest? — Neutral

CNM   Zacks Investment Research — November 28, 2025

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

image for news Wall Street Analysts See Core & Main (CNM) as a Buy: Should You Invest?

Earnings Growth & Price Strength Make Virtu Financial (VIRT) a Stock to Watch — Positive

VIRT   Zacks Investment Research — November 28, 2025

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

image for news Earnings Growth & Price Strength Make Virtu Financial (VIRT) a Stock to Watch

Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It? — Positive

VKTX   Zacks Investment Research — November 28, 2025

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?

Is Nu (NU) a Buy as Wall Street Analysts Look Optimistic? — Neutral

NU   Zacks Investment Research — November 28, 2025

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

image for news Is Nu (NU) a Buy as Wall Street Analysts Look Optimistic?